Expression of a mutated form of the p85α regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO) (original) (raw)

References

  1. Küppers R, Rajewsky K . The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease Annu Rev Immunol 1998 16: 471–493
    Article Google Scholar
  2. Seitz V, Hummel M, Marafioti T, Anagnostopoulos I, Assaf C, Stein H . Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed–Sternberg cells of classic Hodgkin disease Blood 2000 95: 3020–3024
    CAS PubMed Google Scholar
  3. Herbst H, Dallenbach F, Hummel M, Niedobitek G, Pileri S, Muller-Lantzsch N, Stein H . Epstein–Barr virus latent membrane protein expression in Hodgkin and Reed–Sternberg cells Proc Natl Acad Sci USA 1991 88: 4766–4770
    Article CAS Google Scholar
  4. Jücker M, Abts H, Li W, Schindler R, Merz H, Günther A, von Kalle C, Schaadt M, Diamantstein T, Feller AC, Krueger GRF, Diehl V, Blankenstein T, Tesch H . Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease Blood 1991 77: 2413–2418
    PubMed Google Scholar
  5. Herbst H, Samol J, Foss HD, Raff T, Niedobitek G . Modulation of interleukin-6 expression in Hodgkin and Reed–Sternberg cells by Epstein–Barr virus J Pathol 1997 182: 299–306
    Article CAS Google Scholar
  6. Jücker M, Schaadt M, Diehl V, Poppema S, Jones D, Tesch H . Heterogeneous expression of proto-oncogenes in Hodgkin's disease derived cell lines Hematol Oncol 1990 8: 191–204
    Article Google Scholar
  7. Jücker M, Roebroek AJM, Mautner J, Koch K, Eick D, Diehl V, Van de Ven WJM, Tesch H . Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines Oncogene 1992 7: 943–952
    PubMed Google Scholar
  8. Trümper LH, Brady G, Bagg A, Gray D, Loke SL, Griesser H, Wagmann R, Braziel R, Gascoyne RD, Vicini S, Iscove NN, Cossman J, Mak TW . Single cell analysis of Hodgkin and Reed–Sternberg cells: molecular heterogeneity of gene expression and p53 mutations Blood 1993 81: 3097–3115
    PubMed Google Scholar
  9. Kapeller R, Cantley LC . Phosphatidylinositol 3-kinase BioEssays 1994 16: 565–576
    Article CAS Google Scholar
  10. Panayotou G, Waterfield MD . Phosphatidylinositol 3-kinase a key enzyme in diverse signaling pathways Trends Cell Biol 1992 2: 358–360
    Article CAS Google Scholar
  11. Stephens LR, Jackson TR, Hawkins PT . Agonist-stimulated synthesis of phosphatidylinositol(3,4,5)-trisphosphate: a new intracellular signaling system? Biochem Biophys Acta 1993 1179: 27–75
    Article CAS Google Scholar
  12. Scharenberg AM, El-Hillal O, Fruman DA, Beitz LO, Li Z, Lin S, Gout I, Cantley LC, Rawlings DJ, Kinet JP . Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals EMBO J 1998 17: 1961–1972
    Article CAS Google Scholar
  13. Klippel A, Kavanaugh WM, Pot D, Williams LT . A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase akt through its pleckstrin homology domain Mol Cell Biol 1997 17: 338–344
    Article CAS Google Scholar
  14. Scheid MP, Lauener RW, Duronio V . Role of phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in haemopoietic cells: phosphatidylinositol 3-OH-kinase inhibitors reveal a difference in signaling between interleukin-3 and granulocyte-macrophage colony stimulating factor Biochem J 1995 312: 159–162
    Article CAS Google Scholar
  15. Kulik G, Klippel A, Weber MJ . Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt Mol Cell Biol 1997 17: 1595–1606
    Article CAS Google Scholar
  16. Häusler P, Papoff G, Eramo A, Reif K, Cantrell DA, Ruberti G . Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B Eur J Immunol 1998 28: 57–69
    Article Google Scholar
  17. Chang HW, Aoki M, Fruman D, Auger KR, Bellacosa A, Tsichlis PN, Cantley LC, Roberts TM, Vogt PK . Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase Science 1997 276: 1848–1850
    Article CAS Google Scholar
  18. Bellacosa A, Testa JR, Staal SP, Tsichlis PN . A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region Science 1991 254: 274–277
    Article CAS Google Scholar
  19. Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN, Calabretta B . Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway EMBO J 1997 16: 6151–6161
    Article CAS Google Scholar
  20. Fukui Y, Hanafusa H . Phosphatidylinositol kinase activity associates with viral src protein Mol Cell Biol 1989 9: 1651–1658
    Article CAS Google Scholar
  21. Varticovski L, Daley GQ, Jackson P, Baltimore D, Cantley LC . Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants Mol Cell Biol 1991 11: 1107–1113
    Article CAS Google Scholar
  22. Escobedo JA, Navankasattusas S, Kavanaugh WM, Milfay D, Fried VA, Williams LT . cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF beta-receptor Cell 1991 65: 75–82
    Article CAS Google Scholar
  23. Otsu M, Hiles I, Gout I, Fry MJ, Ruiz-Larrea F, Panayotou G, Thompson A, Dhand R, Hsuan J, Totty N, Smith AD, Morgan SJ, Courtneidge AA, Parker PJ, Waterfield MD . Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase Cell 1991 65: 91–104
    Article CAS Google Scholar
  24. Skolnik EY, Margolis B, Mohammadi M, Lowenstein E, Fischer R, Drepps A, Ullrich A, Schlessinger J . Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases Cell 1991 65: 83–90
    Article CAS Google Scholar
  25. Klippel A, Escobedo JA, Hu Q, Williams LT . A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo Mol Cell Biol 1993 13: 5560–5566
    Article CAS Google Scholar
  26. Antonetti DA, Algenstaedt P, Kahn CR . Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain Mol Cell Biol 1996 16: 2195–2203
    Article CAS Google Scholar
  27. Pons S, Asano T, Glasheen E, Miralpeix M, Zhang Y, Fisher TL, Myers MG, Sun XJ, Morris MF . The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase Mol Cell Biol 1995 15: 4453–4465
    Article CAS Google Scholar
  28. Hu P, Margolis B, Skolnik EY, Lammers R, Ullrich A, Schlessinger J . Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors Mol Cell Biol 1992 12: 981–990
    Article CAS Google Scholar
  29. McGlade CJ, Ellis C, Reedijk M, Anderson D, Mbamalu G, Reith AD, Panayotou G, End P, Bernstein A, Kazlauskas A, Waterfield MD, Pawson T . SH2 domains of the p85 alpha subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors Mol Cell Biol 1992 12: 991–997
    Article CAS Google Scholar
  30. Pleiman CM, Hertz WM, Cambier JC . Activation of phosphatidylinositol-3′kinase by src family kinase SH3 binding to the p85 subunit Science 1994 263: 1609–1612
    Article CAS Google Scholar
  31. Jiminez C, Jones DR, Rodriguez-Viciana P, Gonzalez-Garcia A, Leonardo E, Wennstöm S, von Kobbe C, Toran JL, Borlado LR, Calvo V, Copin SG, Albar JP, Gaspar ML, Diez E, Marcos MAR, Downward J, Martinez C, Merida I, Carrera AC . Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase EMBO J 1988 17: 743–753
    Article Google Scholar
  32. Borlado LR, Redondo C, Alvarez B, Jimenez C, Criado LM, Flores J, Marcos MAR, Martinez C, Balomenos D, Carrera AC . Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo FASEB J 2000 14: 895–903
    Article CAS Google Scholar
  33. Schaadt M, Diehl V, Stein H, Fonatsch C, Kirchner H . Two neoplastic cell lines with unique features derived from Hodgkin's disease Int J Cancer 1980 26: 723–731
    Article CAS Google Scholar
  34. Diehl V, Kirchner HH, Schaadt M, Fonatsch C, Stein H, Gerdes J, Boie C . Hodgkin's disease: establishment and characterization of four in vitro cell lines J Cancer Res Clin Oncol 1981 101: 111–124
    Article CAS Google Scholar
  35. Diehl V, Kirchner HH, Burrichter H, Stein H, Fonatsch C, Gerdes J, Schaadt M, Heit W, Uchanska-Ziegler B, Ziegler A, Heintz F, Sueno K . Characteristics of Hodgkin's disease-derived cell lines Cancer Treat Rep 1982 66: 615–632
    CAS PubMed Google Scholar
  36. Jones DB, Scott CS, Wright DH, Stein H, Beverley PC, Payne SV, Crawford DH . Phenotypic analysis of an established cell line derived from a patient with Hodgkin's disease (HD) Hematol Oncol 1985 3: 133–145
    Article CAS Google Scholar
  37. Poppema S, De Jong B, Atmosoerodjo J, Idenburg V, Visser L, De Ley L . Morphologic, immunologic, enzymehistochemical and chromosomal analysis of a cell line derived from Hodgkin's disease. Evidence for a B-cell origin of Sternberg–Reed cells Cancer 1985 55: 683–690
    Article CAS Google Scholar
  38. Kamesaki H, Fukuhara S, Tatsumi E, Uchino H, Yamabe H, Miwa H, Shirakawa S, Hatanaka M, Honjo T . Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease Blood 1986 68: 285–292
    CAS PubMed Google Scholar
  39. Drexler HG, Gaedicke G, Lok MS, Diehl V, Minowada J . Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles Leuk Res 1986 10: 487–500
    Article CAS Google Scholar
  40. Woscholski R, Kodaki T, McKinnon M, Waterfield MD, Parker PJ . A comparison of demethoxyviridin and wortmannin as inhibitors of phosphatidylinositol 3-kinase FEBS Lett 1994 342: 109–114
    Article CAS Google Scholar
  41. Sanger F . Determination of nucleotide sequences in DNA Science 1981 214: 1205–1210
    Article CAS Google Scholar
  42. Horn S, Meyer J, Heukeshoven J, Fehse B, Schulze C, Li S, Frey J, Poll S, Stocking C, Jücker M . The Inositol 5-phosphatase SHIP is expressed as 145 and 135 kD proteins in blood and bone marrow cells in vivo, whereas carboxyl-truncated forms of SHIP are generated by proteolytic cleavage in vitro Leukemia 2001 15: 112–120
    Article CAS Google Scholar
  43. Jücker M, Schiffer CA, Feldman RA . A tyrosine-phosphorylated protein of 140 kD is constitutively associated with the phosphotyrosine binding domain of Shc and the SH3 domains of Grb2 in acute myeloid leukemia cells Blood 1997 89: 2024–2035
    PubMed Google Scholar
  44. Areces LB, Jücker M, San Miguel JA, Mui A, Miyajima A, Feldman RA . Ligand-dependent transformation by the receptor for human granulocyte/macrophage colony-stimulating factor and tyrosine phosphorylation of the receptor beta subunit Proc Natl Acad Sci USA 1993 90: 3963–3967
    Article CAS Google Scholar
  45. Jücker M, Feldman RA . Identification of a new adaptor protein that may link the common β subunit of the receptor for granulocyte/macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 to phosphatidylinositol 3-kinase J Biol Chem 1995 270: 27817–27822
    Article Google Scholar
  46. Fruman DA, Cantley LC, Caroenter CL . Structural organization and alternative splicing of the murine phosphoinositide 3-kinase p85α gene Genomics 1996 37: 113–121
    Article CAS Google Scholar
  47. Hu P, Mondino A, Skolnik EY, Schlessinger J . Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85 Mol Cell Biol 1993 13: 7677–7688
    Article CAS Google Scholar
  48. Dhand R, Hara K, Hiles I, Bax B, Gout I, Panayotou G, Fry MJ, Yonezawa K, Kasuga M, Waterfield MD . PI 3-kinase: structureal and functional analysis of intersubunit interactions EMBO J 1994 13: 511–522
    Article CAS Google Scholar
  49. Franke TF, Kaplan TR, Cantley LC . PI3K: downstream AKTion blocks apoptosis Cell 1997 88: 435–437
    Article CAS Google Scholar
  50. Scheid PS, Duronio V . Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/Akt: Involvement of MEK upstream of Bad phosphorylation Proc Natl Acad Sci USA 1998 95: 7439–7444
    Article CAS Google Scholar
  51. Chan TO, Rittenhouse SE, Tsichlis PN . Akt/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation Annu Rev Biochem 1999 68: 965–1014
    Article CAS Google Scholar
  52. Hill MM, Andjelkovic M, Brazil DP, Ferrari S, Fabbro D, Hemming BA . Insulin-stimulated protein kinase B phosphorylation ser-473 is independent of its activity and occurs through a staurosporine-insensitive kinase J Biol Chem 2001 28: 25643–25646
    Article Google Scholar
  53. Waksman G, Kominos D, Robertson SC, Pant N, Baltimore D, Birge RB, Cowburn D, Hanafusa H, Mayer BJ, Overduin M, Resh MD, Rios CB, Silverman L, Kuriyan J . Crystal structure of the phosphotyrosine recogniton domain SH2 of v-src complexed with tyrosine-phosphorylated peptides Nature 1992 358: 646–653
    Article CAS Google Scholar
  54. Mayer BJ, Jackson PK, Van Etten RA, Baltimore D . Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo Mol Cell Biol 1992 12: 609–618
    Article CAS Google Scholar
  55. Siegal G, Davis B, Kristensen SM, Sankar A, Linacre J, Stein RC, Panayotou G, Waterfield MD, Discoll PC . Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase J Mol Biol 1998 276: 461–478
    Article CAS Google Scholar
  56. Klein S, Jones DB, Tesch H . In vitro differentiation of a Hodgkin's disease derived cell line Hematol Oncol 1992 10: 195–205
    Article CAS Google Scholar
  57. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky A, Lechleider R, Neel BG, Birge RB, Fajardo JE, Chou MM, Hanafusa H, Schaffhausen B, Cantley L . SH2 domains recognize specific phosphopeptide sequences Cell 1993 72: 767–778
    Article CAS Google Scholar
  58. Ponzetto C, Bardelli A, Maina F, Longati P, Panayotou G, Dhand R, Waterfield MD, Comoglio PM . A novel recogniton motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor Mol Cell Biol 1993 13: 4600–4608
    Article CAS Google Scholar
  59. Klippel A, Escobedo JA, Fantl WJ, Williams LT . The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidylinositol 3-kinase to phosphorylated platelet-derived growth factor β receptor Mol Cell Biol 1992 12: 1451–1459
    Article CAS Google Scholar
  60. Kavanaugh WM, Klippel A, Escobedo JA, Williams LT . Modification of the 85-kilodalton subunit of phosphatidylinositol-3 kinase in platelet-derived growth factor-stimulated cells Mol Cell Biol 1992 12: 3415–3424
    Article CAS Google Scholar
  61. Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA, Backer JM . Regulation of the p85/p110 phosphatidylinositol 3′-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit Mol Cell Biol 1998 18: 1379–1387
    Article CAS Google Scholar
  62. Yu J, Wjasow C, Backer JM . Regulation of the p85/p110alpha phosphatidylinositol 3′-kinase J Biol Chem 1998 273: 30199–30203
    Article CAS Google Scholar
  63. Daduang S, Nagata S, Matsuda M, Yamori T, Onodera K, Fukui Y . Production of monoclonal antibodies specific to the carboxyl terminal region of the 85 kDa subunit of phosphatidylinositol 3-kinase: use of the antibodies in recogniton of mutant p85 Immunol Cell Biol 1995 73: 134–139
    Article CAS Google Scholar
  64. Mitelman F . Chromosome 5. In: Johansson B, Mertens F (eds) Catalog of Chromosome Aberrations in Cancer, 5th edn Wiley-Liss: New York, NY 1994 681–704
    Google Scholar

Download references